APO Research
Talk to an analyst

APO RESEARCH · REPORT

Laser Benign Prostatic Hyperplasia (BPH) Devices

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Laser Benign Prostatic Hyperplasia (BPH) Devices Market Outlook and Growth Opportunities 2026

4 July 2026196 pages

Choose your research edition.

Industry ResearchLaser Benign Prostatic Hyperplasia (BPH) Devices Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Laser Benign Prostatic Hyperplasia (BPH) Devices Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Laser Benign Prostatic Hyperplasia (BPH) Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Laser Benign Prostatic Hyperplasia (BPH) Devices Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Laser Benign Prostatic Hyperplasia (BPH) Devices Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Laser Benign Prostatic Hyperplasia (BPH) Devices market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Laser Benign Prostatic Hyperplasia (BPH) Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Laser Benign Prostatic Hyperplasia (BPH) Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Laser Benign Prostatic Hyperplasia (BPH) Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Laser Benign Prostatic Hyperplasia (BPH) Devices market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Laser Benign Prostatic Hyperplasia (BPH) Devices market include Urovision-Urotech, Urologix, Teleflex Incorporated, Richard Wolf, ProArc Medical, Olympus Winter, Lumenis, LISA Laser and KARL STORZ, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Laser Benign Prostatic Hyperplasia (BPH) Devices market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Laser Benign Prostatic Hyperplasia (BPH) Devices and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Laser Benign Prostatic Hyperplasia (BPH) Devices sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Laser Benign Prostatic Hyperplasia (BPH) Devices market size, projected growth trends, production technologies, key applications, and end-use industries.

Laser Benign Prostatic Hyperplasia (BPH) Devices Segment by Company

Urovision-Urotech

Urologix

Teleflex Incorporated

Richard Wolf

ProArc Medical

Olympus Winter

Lumenis

LISA Laser

KARL STORZ

Endo Pharmaceuticals

Coloplast Corp

Boston Scientific Corporation

Biolitec

BD

Laser Benign Prostatic Hyperplasia (BPH) Devices Segment by Type

Fixed

Trolley Mounted

Laser Benign Prostatic Hyperplasia (BPH) Devices Segment by Application

Ambulatory Surgical Centres (ASC)

Urology Centre

Hospitals

Speciality Clinics

Others

Laser Benign Prostatic Hyperplasia (BPH) Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Laser Benign Prostatic Hyperplasia (BPH) Devices status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Laser Benign Prostatic Hyperplasia (BPH) Devices market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Laser Benign Prostatic Hyperplasia (BPH) Devices significant trends, drivers, influence factors in global and regions.

6. To analyze Laser Benign Prostatic Hyperplasia (BPH) Devices competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Laser Benign Prostatic Hyperplasia (BPH) Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Laser Benign Prostatic Hyperplasia (BPH) Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Laser Benign Prostatic Hyperplasia (BPH) Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Laser Benign Prostatic Hyperplasia (BPH) Devices market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Laser Benign Prostatic Hyperplasia (BPH) Devices industry.

Chapter 3: Detailed analysis of Laser Benign Prostatic Hyperplasia (BPH) Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Laser Benign Prostatic Hyperplasia (BPH) Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Laser Benign Prostatic Hyperplasia (BPH) Devices in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Laser Benign Prostatic Hyperplasia (BPH) Devices Industry Trends Table 2. Laser Benign Prostatic Hyperplasia (BPH) Devices Industry Drivers Table 3. Laser Benign Prostatic Hyperplasia (BPH) Devices Industry Opportunities and Challenges Table 4. Laser Benign Prostatic Hyperplasia (BPH) Devices Industry Restraints Table 5. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Revenue Share by Company (2021-2026) Table 7. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Volume by Company (k units) & (2021-2026) Table 8. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Volume Share by Company (2021-2026) Table 9. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Average Price (USD/unit) of Company (2021-2026) Table 10. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Company Ranking, (2024-2026) & (USD Million) Table 11. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Key Company Manufacturing Base & Headquarters Table 12. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Company, Product Type & Application Table 13. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Laser Benign Prostatic Hyperplasia (BPH) Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Fixed Table 18. Significant Companies of Trolley Mounted Table 19. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Volume by Type (2021-2026) & (k units) Table 21. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Volume by Type (2027-2032) & (k units) Table 22. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Volume Share by Type (2021-2026) Table 23. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Volume Share by Type (2027-2032) Table 24. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type (2021-2026) Table 28. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Ambulatory Surgical Centres (ASC) Table 30. Significant Companies of Urology Centre Table 31. Significant Companies of Hospitals Table 32. Significant Companies of Speciality Clinics Table 33. Significant Companies of Others Table 34. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Volume by Application (2021-2026) & (k units) Table 36. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Volume by Application (2027-2032) & (k units) Table 37. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Volume Share by Application (2021-2026) Table 38. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Volume Share by Application (2027-2032) Table 39. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application (2021-2026) Table 43. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application (2027-2032) Table 44. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales by Region (2021-2026) & (k units) Table 46. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Market Share by Region (2021-2026) Table 47. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales by Region (2027-2032) & (k units) Table 48. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Market Share by Region (2027-2032) Table 49. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Region (2021-2026) Table 52. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Region (2027-2032) Table 54. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Market Average Price (USD/unit) by Region (2021-2026) Table 55. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Market Average Price (USD/unit) by Region (2027-2032) Table 56. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 57. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales by Country (2021-2026) & (k units) Table 59. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Market Share by Country (2021-2026) Table 60. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales by Country (2027-2032) & (k units) Table 61. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Market Share by Country (2027-2032) Table 62. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Market Share by Country (2021-2026) Table 64. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Market Share by Country (2027-2032) Table 66. Urovision-Urotech Company Information Table 67. Urovision-Urotech Business Overview Table 68. Urovision-Urotech Laser Benign Prostatic Hyperplasia (BPH) Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 69. Urovision-Urotech Laser Benign Prostatic Hyperplasia (BPH) Devices Product Portfolio Table 70. Urovision-Urotech Recent Development Table 71. Urologix Company Information Table 72. Urologix Business Overview Table 73. Urologix Laser Benign Prostatic Hyperplasia (BPH) Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 74. Urologix Laser Benign Prostatic Hyperplasia (BPH) Devices Product Portfolio Table 75. Urologix Recent Development Table 76. Teleflex Incorporated Company Information Table 77. Teleflex Incorporated Business Overview Table 78. Teleflex Incorporated Laser Benign Prostatic Hyperplasia (BPH) Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 79. Teleflex Incorporated Laser Benign Prostatic Hyperplasia (BPH) Devices Product Portfolio Table 80. Teleflex Incorporated Recent Development Table 81. Richard Wolf Company Information Table 82. Richard Wolf Business Overview Table 83. Richard Wolf Laser Benign Prostatic Hyperplasia (BPH) Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 84. Richard Wolf Laser Benign Prostatic Hyperplasia (BPH) Devices Product Portfolio Table 85. Richard Wolf Recent Development Table 86. ProArc Medical Company Information Table 87. ProArc Medical Business Overview Table 88. ProArc Medical Laser Benign Prostatic Hyperplasia (BPH) Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. ProArc Medical Laser Benign Prostatic Hyperplasia (BPH) Devices Product Portfolio Table 90. ProArc Medical Recent Development Table 91. Olympus Winter Company Information Table 92. Olympus Winter Business Overview Table 93. Olympus Winter Laser Benign Prostatic Hyperplasia (BPH) Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Olympus Winter Laser Benign Prostatic Hyperplasia (BPH) Devices Product Portfolio Table 95. Olympus Winter Recent Development Table 96. Lumenis Company Information Table 97. Lumenis Business Overview Table 98. Lumenis Laser Benign Prostatic Hyperplasia (BPH) Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Lumenis Laser Benign Prostatic Hyperplasia (BPH) Devices Product Portfolio Table 100. Lumenis Recent Development Table 101. LISA Laser Company Information Table 102. LISA Laser Business Overview Table 103. LISA Laser Laser Benign Prostatic Hyperplasia (BPH) Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. LISA Laser Laser Benign Prostatic Hyperplasia (BPH) Devices Product Portfolio Table 105. LISA Laser Recent Development Table 106. KARL STORZ Company Information Table 107. KARL STORZ Business Overview Table 108. KARL STORZ Laser Benign Prostatic Hyperplasia (BPH) Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. KARL STORZ Laser Benign Prostatic Hyperplasia (BPH) Devices Product Portfolio Table 110. KARL STORZ Recent Development Table 111. Endo Pharmaceuticals Company Information Table 112. Endo Pharmaceuticals Business Overview Table 113. Endo Pharmaceuticals Laser Benign Prostatic Hyperplasia (BPH) Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Endo Pharmaceuticals Laser Benign Prostatic Hyperplasia (BPH) Devices Product Portfolio Table 115. Endo Pharmaceuticals Recent Development Table 116. Coloplast Corp Company Information Table 117. Coloplast Corp Business Overview Table 118. Coloplast Corp Laser Benign Prostatic Hyperplasia (BPH) Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Coloplast Corp Laser Benign Prostatic Hyperplasia (BPH) Devices Product Portfolio Table 120. Coloplast Corp Recent Development Table 121. Boston Scientific Corporation Company Information Table 122. Boston Scientific Corporation Business Overview Table 123. Boston Scientific Corporation Laser Benign Prostatic Hyperplasia (BPH) Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Boston Scientific Corporation Laser Benign Prostatic Hyperplasia (BPH) Devices Product Portfolio Table 125. Boston Scientific Corporation Recent Development Table 126. Biolitec Company Information Table 127. Biolitec Business Overview Table 128. Biolitec Laser Benign Prostatic Hyperplasia (BPH) Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. Biolitec Laser Benign Prostatic Hyperplasia (BPH) Devices Product Portfolio Table 130. Biolitec Recent Development Table 131. BD Company Information Table 132. BD Business Overview Table 133. BD Laser Benign Prostatic Hyperplasia (BPH) Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. BD Laser Benign Prostatic Hyperplasia (BPH) Devices Product Portfolio Table 135. BD Recent Development Table 136. Key Raw Materials Table 137. Raw Materials Key Suppliers Table 138. Laser Benign Prostatic Hyperplasia (BPH) Devices Distributors List Table 139. Laser Benign Prostatic Hyperplasia (BPH) Devices Customers List Table 140. Research Programs/Design for This Report Table 141. Authors List of This Report Table 142. Secondary Sources Table 143. Primary Sources List of Figures Figure 1. Laser Benign Prostatic Hyperplasia (BPH) Devices Product Image Figure 2. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value (2021-2032) & (US$ Million) Figure 4. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales (2021-2032) & (k units) Figure 5. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Fixed Image Figure 10. Trolley Mounted Image Figure 11. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Volume Share by Type (2021-2032) Figure 14. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type (2021-2032) Figure 17. Ambulatory Surgical Centres (ASC) Image Figure 18. Urology Centre Image Figure 19. Hospitals Image Figure 20. Speciality Clinics Image Figure 21. Others Image Figure 22. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Volume Share by Application (2021-2032) Figure 25. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application (2021-2032) Figure 28. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 29. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value (2021-2032) & (US$ Million) Figure 33. North America Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value (2021-2032) & (US$ Million) Figure 39. South America Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Laser Benign Prostatic Hyperplasia (BPH) Devices Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Fixed
  • Trolley Mounted
Applications
  • Ambulatory Surgical Centres (ASC)
  • Urology Centre
  • Hospitals
  • Speciality Clinics
  • Others
Companies covered
  • Urovision-Urotech
  • Urologix
  • Teleflex Incorporated
  • Richard Wolf
  • ProArc Medical
  • Olympus Winter
  • Lumenis
  • LISA Laser
  • KARL STORZ
  • Endo Pharmaceuticals
  • Coloplast Corp
  • Boston Scientific Corporation
  • Biolitec
  • BD

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value (2021-2032)
  4. 1.2.2 Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Volume (2021-2032)
  5. 1.2.3 Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Laser Benign Prostatic Hyperplasia (BPH) Devices Market Dynamics
  1. 2.1 Laser Benign Prostatic Hyperplasia (BPH) Devices Industry Trends
  2. 2.2 Laser Benign Prostatic Hyperplasia (BPH) Devices Industry Drivers
  3. 2.3 Laser Benign Prostatic Hyperplasia (BPH) Devices Industry Opportunities and Challenges
  4. 2.4 Laser Benign Prostatic Hyperplasia (BPH) Devices Industry Restraints
3 Laser Benign Prostatic Hyperplasia (BPH) Devices Market by Company
  1. 3.1 Global Laser Benign Prostatic Hyperplasia (BPH) Devices Company Revenue Ranking in 2025
  2. 3.2 Global Laser Benign Prostatic Hyperplasia (BPH) Devices Revenue by Company (2021-2026)
  3. 3.3 Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Volume by Company (2021-2026)
  4. 3.4 Global Laser Benign Prostatic Hyperplasia (BPH) Devices Average Price by Company (2021-2026)
  5. 3.5 Global Laser Benign Prostatic Hyperplasia (BPH) Devices Company Ranking (2024-2026)
  6. 3.6 Global Laser Benign Prostatic Hyperplasia (BPH) Devices Company Manufacturing Base and Headquarters
  7. 3.7 Global Laser Benign Prostatic Hyperplasia (BPH) Devices Company Product Type and Application
  8. 3.8 Global Laser Benign Prostatic Hyperplasia (BPH) Devices Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Laser Benign Prostatic Hyperplasia (BPH) Devices Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Laser Benign Prostatic Hyperplasia (BPH) Devices Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Laser Benign Prostatic Hyperplasia (BPH) Devices Market by Type
  1. 4.1 Laser Benign Prostatic Hyperplasia (BPH) Devices Type Introduction
  2. 4.1.1 Fixed
  3. 4.1.2 Trolley Mounted
  4. 4.2 Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Volume by Type
  5. 4.2.1 Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value by Type
  9. 4.3.1 Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value by Type (2021-2032)
  11. 4.3.3 Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type (2021-2032)
5 Laser Benign Prostatic Hyperplasia (BPH) Devices Market by Application
  1. 5.1 Laser Benign Prostatic Hyperplasia (BPH) Devices Application Introduction
  2. 5.1.1 Ambulatory Surgical Centres (ASC)
  3. 5.1.2 Urology Centre
  4. 5.1.3 Hospitals
  5. 5.1.4 Speciality Clinics
  6. 5.1.5 Others
  7. 5.2 Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Volume by Application
  8. 5.2.1 Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value by Application
  12. 5.3.1 Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value by Application (2021-2032)
  14. 5.3.3 Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application (2021-2032)
6 Laser Benign Prostatic Hyperplasia (BPH) Devices Regional Sales and Value Analysis
  1. 6.1 Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales by Region (2021-2032)
  3. 6.2.1 Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales by Region: 2021-2026
  4. 6.2.2 Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales by Region (2027-2032)
  5. 6.3 Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value by Region (2021-2032)
  7. 6.4.1 Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value by Region: 2021-2026
  8. 6.4.2 Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value by Region (2027-2032)
  9. 6.5 Global Laser Benign Prostatic Hyperplasia (BPH) Devices Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value (2021-2032)
  12. 6.6.2 North America Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value (2021-2032)
  15. 6.7.2 Europe Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value (2021-2032)
  21. 6.9.2 South America Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Country, 2025 VS 2032
7 Laser Benign Prostatic Hyperplasia (BPH) Devices Country-level Sales and Value Analysis
  1. 7.1 Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales by Country (2021-2032)
  4. 7.3.1 Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales by Country (2021-2026)
  5. 7.3.2 Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales by Country (2027-2032)
  6. 7.4 Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value by Country (2021-2032)
  7. 7.4.1 Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value by Country (2021-2026)
  8. 7.4.2 Global Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Urovision-Urotech
  2. 8.1.1 Urovision-Urotech Company Information
  3. 8.1.2 Urovision-Urotech Business Overview
  4. 8.1.3 Urovision-Urotech Laser Benign Prostatic Hyperplasia (BPH) Devices Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Urovision-Urotech Laser Benign Prostatic Hyperplasia (BPH) Devices Product Portfolio
  6. 8.1.5 Urovision-Urotech Recent Developments
  7. 8.2 Urologix
  8. 8.2.1 Urologix Company Information
  9. 8.2.2 Urologix Business Overview
  10. 8.2.3 Urologix Laser Benign Prostatic Hyperplasia (BPH) Devices Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Urologix Laser Benign Prostatic Hyperplasia (BPH) Devices Product Portfolio
  12. 8.2.5 Urologix Recent Developments
  13. 8.3 Teleflex Incorporated
  14. 8.3.1 Teleflex Incorporated Company Information
  15. 8.3.2 Teleflex Incorporated Business Overview
  16. 8.3.3 Teleflex Incorporated Laser Benign Prostatic Hyperplasia (BPH) Devices Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Teleflex Incorporated Laser Benign Prostatic Hyperplasia (BPH) Devices Product Portfolio
  18. 8.3.5 Teleflex Incorporated Recent Developments
  19. 8.4 Richard Wolf
  20. 8.4.1 Richard Wolf Company Information
  21. 8.4.2 Richard Wolf Business Overview
  22. 8.4.3 Richard Wolf Laser Benign Prostatic Hyperplasia (BPH) Devices Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Richard Wolf Laser Benign Prostatic Hyperplasia (BPH) Devices Product Portfolio
  24. 8.4.5 Richard Wolf Recent Developments
  25. 8.5 ProArc Medical
  26. 8.5.1 ProArc Medical Company Information
  27. 8.5.2 ProArc Medical Business Overview
  28. 8.5.3 ProArc Medical Laser Benign Prostatic Hyperplasia (BPH) Devices Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 ProArc Medical Laser Benign Prostatic Hyperplasia (BPH) Devices Product Portfolio
  30. 8.5.5 ProArc Medical Recent Developments
  31. 8.6 Olympus Winter
  32. 8.6.1 Olympus Winter Company Information
  33. 8.6.2 Olympus Winter Business Overview
  34. 8.6.3 Olympus Winter Laser Benign Prostatic Hyperplasia (BPH) Devices Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Olympus Winter Laser Benign Prostatic Hyperplasia (BPH) Devices Product Portfolio
  36. 8.6.5 Olympus Winter Recent Developments
  37. 8.7 Lumenis
  38. 8.7.1 Lumenis Company Information
  39. 8.7.2 Lumenis Business Overview
  40. 8.7.3 Lumenis Laser Benign Prostatic Hyperplasia (BPH) Devices Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Lumenis Laser Benign Prostatic Hyperplasia (BPH) Devices Product Portfolio
  42. 8.7.5 Lumenis Recent Developments
  43. 8.8 LISA Laser
  44. 8.8.1 LISA Laser Company Information
  45. 8.8.2 LISA Laser Business Overview
  46. 8.8.3 LISA Laser Laser Benign Prostatic Hyperplasia (BPH) Devices Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 LISA Laser Laser Benign Prostatic Hyperplasia (BPH) Devices Product Portfolio
  48. 8.8.5 LISA Laser Recent Developments
  49. 8.9 KARL STORZ
  50. 8.9.1 KARL STORZ Company Information
  51. 8.9.2 KARL STORZ Business Overview
  52. 8.9.3 KARL STORZ Laser Benign Prostatic Hyperplasia (BPH) Devices Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 KARL STORZ Laser Benign Prostatic Hyperplasia (BPH) Devices Product Portfolio
  54. 8.9.5 KARL STORZ Recent Developments
  55. 8.10 Endo Pharmaceuticals
  56. 8.10.1 Endo Pharmaceuticals Company Information
  57. 8.10.2 Endo Pharmaceuticals Business Overview
  58. 8.10.3 Endo Pharmaceuticals Laser Benign Prostatic Hyperplasia (BPH) Devices Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Endo Pharmaceuticals Laser Benign Prostatic Hyperplasia (BPH) Devices Product Portfolio
  60. 8.10.5 Endo Pharmaceuticals Recent Developments
  61. 8.11 Coloplast Corp
  62. 8.11.1 Coloplast Corp Company Information
  63. 8.11.2 Coloplast Corp Business Overview
  64. 8.11.3 Coloplast Corp Laser Benign Prostatic Hyperplasia (BPH) Devices Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Coloplast Corp Laser Benign Prostatic Hyperplasia (BPH) Devices Product Portfolio
  66. 8.11.5 Coloplast Corp Recent Developments
  67. 8.12 Boston Scientific Corporation
  68. 8.12.1 Boston Scientific Corporation Company Information
  69. 8.12.2 Boston Scientific Corporation Business Overview
  70. 8.12.3 Boston Scientific Corporation Laser Benign Prostatic Hyperplasia (BPH) Devices Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Boston Scientific Corporation Laser Benign Prostatic Hyperplasia (BPH) Devices Product Portfolio
  72. 8.12.5 Boston Scientific Corporation Recent Developments
  73. 8.13 Biolitec
  74. 8.13.1 Biolitec Company Information
  75. 8.13.2 Biolitec Business Overview
  76. 8.13.3 Biolitec Laser Benign Prostatic Hyperplasia (BPH) Devices Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Biolitec Laser Benign Prostatic Hyperplasia (BPH) Devices Product Portfolio
  78. 8.13.5 Biolitec Recent Developments
  79. 8.14 BD
  80. 8.14.1 BD Company Information
  81. 8.14.2 BD Business Overview
  82. 8.14.3 BD Laser Benign Prostatic Hyperplasia (BPH) Devices Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 BD Laser Benign Prostatic Hyperplasia (BPH) Devices Product Portfolio
  84. 8.14.5 BD Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Laser Benign Prostatic Hyperplasia (BPH) Devices Value Chain Analysis
  2. 9.1.1 Laser Benign Prostatic Hyperplasia (BPH) Devices Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Mode & Process
  6. 9.2 Laser Benign Prostatic Hyperplasia (BPH) Devices Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Laser Benign Prostatic Hyperplasia (BPH) Devices Distributors
  9. 9.2.3 Laser Benign Prostatic Hyperplasia (BPH) Devices Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst